Fig. 1From: Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case seriesRespiratory support and outcomes of individual patients. As of May 22, 2020, 1 patient had died, while 7 patients had been extubated. All the patients receiving follow-up monitoring for at least 33 days. ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; IMV, invasive mechanical ventilation; DNR, do-not-resuscitateBack to article page